About AMPRION, INC.
Amprion Diagnostics is a company focused on developing and providing advanced diagnostic tests for neurodegenerative diseases, such as Parkinson’s, Lewy body dementia, and Alzheimer’s, using a validated seed amplification assay technology. The company's mission is to improve the accuracy of diagnosis through biological evidence rather than relying on symptoms alone.
Development and validation of the SAAmplify-ɑSYN seed amplification assay for detecting misfolded α-synuclein in CSFAutopsy-confirmed accuracy in diagnosing neurodegenerative diseasesAnalysis of over 20,000 samples using the seed amplification assaySupport for clinical trials and drug development through FDA-supported technology
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $1.1M | |
| PROTEIN ANALYSIS IN CEREBROSPINAL FLUID SAMPLES | Department of Health and Human Services | $1.1M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AMPRION, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.